TY - JOUR
T1 - FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta
AU - Doyard, Mathilde
AU - Bacrot, Séverine
AU - Huber, Céline
AU - Di Rocco, Maja
AU - Goldenberg, Alice
AU - Aglan, Mona S.
AU - Brunelle, Perrine
AU - Temtamy, Samia
AU - Michot, Caroline
AU - Otaify, Ghada A.
AU - Haudry, Coralie
AU - Castanet, Mireille
AU - Leroux, Julien
AU - Bonnefont, Jean Paul
AU - Munnich, Arnold
AU - Baujat, Geneviève
AU - Lapunzina, Pablo
AU - Monnot, Sophie
AU - Ruiz-Perez, Victor L.
AU - Cormier-Daire, Valérie
N1 - Funding Information:
1Department of Medical genetics, inSerM U1163, Université Paris-Descartes, institut imagine, Hôpital necker-enfants Malades, Paris, France 2Unit of rare Diseases, Department of Pediatrics, giannina gaslini institute, genova, italy 3Department of genetics, centre normand de génomique Médicale et Médecine Personnalisée, cHU de rouen, rouen, France 4Department of clinical genetics. Human genetics and genome research Division, centre of excellence of Human genetics, national research centre, cairo, egypt 5Department of Pediatric, cHU de rouen, rouen, France 6Department of Pediatric Surgery, cHU de rouen, rouen, France 7instituto de genética Médica y Molecular (ingeMM), Hospital Universitario la Paz-idiPaz, Universidad autónoma de Madrid, Madrid, Spain 8ciBer de enfermedades raras (ciBerer), insitituto de Salud carlos iii, Madrid, Spain 9instituto de investigaciones Biomédicas de Madrid, consejo Superior de investigaciones científicas-Universidad autónoma de Madrid, Madrid, Spain Acknowledgements We thank the French association on Osteogenesis imperfecta for their funding support. Part of this work was financially supported by the Spanish Ministry of economy and competitiveness (SaF2013-43365-r/ SaF2016-75434-r to VlrP).
Publisher Copyright:
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
PY - 2018/4
Y1 - 2018/4
N2 - Background Stüve-Wiedemann syndrome (SWS) is characterised by bowing of the lower limbs, respiratory distress and hyperthermia that are often responsible for early death. Survivors develop progressive scoliosis and spontaneous fractures. We previously identified LIFR mutations in most SWS cases, but absence of LIFR pathogenic changes in five patients led us to perform exome sequencing and to identify homozygosity for a FAM46A mutation in one case [p.Ser205Tyrfs∗13]. The follow-up of this case supported a final diagnosis of osteogenesis imperfecta (OI), based on vertebral collapses and blue sclerae. Methods and results This prompted us to screen FAM46A in 25 OI patients with no known mutations. We identified a homozygous deleterious variant in FAM46A in two affected sibs with typical OI [p.His127Arg]. Another homozygous variant, [p.Asp231Gly], also classed as deleterious, was detected in a patient with type III OI of consanguineous parents using homozygosity mapping and exome sequencing. FAM46A is a member of the superfamily of nucleotidyltransferase fold proteins but its exact function is presently unknown. Nevertheless, there are lines of evidence pointing to a relevant role of FAM46A in bone development. By RT-PCR analysis, we detected specific expression of FAM46A in human osteoblasts andinterestingly, a nonsense mutation in Fam46a has been recently identified in an ENU-derived (N-ethyl-N-nitrosourea) mouse model characterised by decreased body length, limb, rib, pelvis, and skull deformities and reduced cortical thickness in long bones. Conclusion We conclude that FAM46A mutations are responsible for a severe form of OI with congenital bowing of the lower limbs and suggest screening this gene in unexplained OI forms.
AB - Background Stüve-Wiedemann syndrome (SWS) is characterised by bowing of the lower limbs, respiratory distress and hyperthermia that are often responsible for early death. Survivors develop progressive scoliosis and spontaneous fractures. We previously identified LIFR mutations in most SWS cases, but absence of LIFR pathogenic changes in five patients led us to perform exome sequencing and to identify homozygosity for a FAM46A mutation in one case [p.Ser205Tyrfs∗13]. The follow-up of this case supported a final diagnosis of osteogenesis imperfecta (OI), based on vertebral collapses and blue sclerae. Methods and results This prompted us to screen FAM46A in 25 OI patients with no known mutations. We identified a homozygous deleterious variant in FAM46A in two affected sibs with typical OI [p.His127Arg]. Another homozygous variant, [p.Asp231Gly], also classed as deleterious, was detected in a patient with type III OI of consanguineous parents using homozygosity mapping and exome sequencing. FAM46A is a member of the superfamily of nucleotidyltransferase fold proteins but its exact function is presently unknown. Nevertheless, there are lines of evidence pointing to a relevant role of FAM46A in bone development. By RT-PCR analysis, we detected specific expression of FAM46A in human osteoblasts andinterestingly, a nonsense mutation in Fam46a has been recently identified in an ENU-derived (N-ethyl-N-nitrosourea) mouse model characterised by decreased body length, limb, rib, pelvis, and skull deformities and reduced cortical thickness in long bones. Conclusion We conclude that FAM46A mutations are responsible for a severe form of OI with congenital bowing of the lower limbs and suggest screening this gene in unexplained OI forms.
KW - calcium and bone
KW - clinical genetics
KW - developmental
UR - http://www.scopus.com/inward/record.url?scp=85044837615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044837615&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2017-104999
DO - 10.1136/jmedgenet-2017-104999
M3 - Article
C2 - 29358272
AN - SCOPUS:85044837615
SN - 0022-2593
VL - 55
SP - 278
EP - 284
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 4
ER -